Revolution Medicines reports positive data for KRAS-targeting cancer drug elironrasib, showing higher response rates vs Amgen ...

Sanofi ends antibody partnership with IGM Biosciences, while Lilly extends Purdue University collaboration with $250M ...

Endpoints platform launches new profile system with improved account management features, including streamlined newsletter ...

Insilico Medicine files third HKEX IPO attempt, as biotech develops rentosertib for IPF and other drugs with AI-driven ...

Corvus Pharmaceuticals reported new Phase 1 data in atopic dermatitis that sent its stock price up by as much as 35% ...

Lonza said on Friday it does not expect any 'material financial impact' from current and potential pharma-specific tariffs.

Takeda revealed a handful of pipeline cuts in its fourth-quarter earnings results on Thursday, as the company focuses its ...

Illumina on Thursday said the SEC has closed its investigation into the company's $8 billion purchase of Grail and doesn't ...

Illumina estimates about $85 million in costs this year related to tariffs on its DNA sequencing products, the company said ...